About Ganglu

Ganglu is a high-tech enterprise that provides key technologies and services for therapetuic materials development in the world. The main members of the company are a group of scientists from European and American universities. It has a professional technical team of more than 50 people and has subsidiaries in Sydney and New York. Autat has established a quality management system in line with international standards, and its partners have GLP qualifications of NMPA, FDA, OECD, MFDs in China and international AAALAC (animal welfare) certification. We can provide customers with basic scientific research, pharmaceutical research and development, reagent and instrument sales, international high-end medical services.

Ganglu (Hefei) Co., Ltd. focuses on providing basic scientific research, therapeutic material development, new therapeutic material preparation and process standardization, patent and article publishing services to customers at home and abroad.

Ganglu (Sydney) Co., Ltd. focuses on providing new therapeutic material introduction, new therapeutic material registration in Australia and bridging Australian customers.

Ganglu (New York) Co., Ltd. focuses on providing service of new therapeutic material introduction into Chinese market, pharmaceutical academic exchange, new therapeutic material FDA registration and bridging American customers. Autat adheres to the purpose of "becoming a booster of new therapeutic material research and development" to protect human health!

About Ganglu

Focus on us

GangLu Biotech

Focus on us